Vanguard Group Inc En V Veno Medical Corp Put Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVNO
# of Institutions
31Shares Held
3.69MCall Options Held
98.5KPut Options Held
6.1K-
Kingdon Capital Management, L.L.C. New York, NY654KShares$2.38 Million0.4% of portfolio
-
Perceptive Advisors LLC New York, NY623KShares$2.27 Million0.09% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT478KShares$1.74 Million0.17% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$1.46 Million3.48% of portfolio
-
Ubs Oconnor LLC Chicago, IL231KShares$840,0750.07% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $34.5M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...